Section Review: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Development of NSAIDs with reduced gastrointestinal and renal toxicity

References

• GARNER A: Adaptation in the pharmaceutical industry, with particular reference to gastrointestinal drugs and diseases. Scand. J. Gastroentera (1992) 27\(Suppl. 193):83–89
   Google Scholar
• SOIL AH, WEINSTEIN WM, KURATA J, MCCARTHY D: Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann. Intern. Med. (1991) 114:307-319. A comprehensive review of the pathogenesis, epidemiology and treatment of NSAID-related gastrointestinal damage.
   Google Scholar
• SEGASOTHY M, SAMAD SA, ZULFIGAR A, BENNETT Di7M: Chronic renal disease and papillary necrosis associated with the long-term use of nonsteroidal anti-inflamma-tory drugs as the sole or predominant analgesic. Am.J. Kidney Dis. (1994) 24:17–24.
   PubMed Web of Science ®Google Scholar
• VANE JR: Inhibition of prostaglandin synthesis as a •meclhanism of action for aspirin-like drugs. Nature NewBiol. (1971) 231: 232-235. First report of the effects of NSAIDs on prostaglandin synthesis, and the suggestion that this would account for both the desired and toxic effects of this class of drugs.
   Google Scholar
• WALLACE JL, TIGLEY AW: New insights into prostagland-ins and mucosal defence. Aliment. Pharmacol. Ther. (1995) 9. In press.
   Google Scholar
• GRAHAM DY: The relationship between nonsteroidal anti-inflammatory drug use and peptic ulcer disease. Gastroenterol. Clinics N. Amer. (1990) 19:171–182.
   PubMed Web of Science ®Google Scholar
• WALLACE JL: Gastric ulceration: Critical events at theneutrophil-endothelium interface. Can.J. Physiol. Phar-macol, (1993) 71:98–102.
   PubMed Web of Science ®Google Scholar
• WALLACE JL, KEENAN CM, GRANGER DN: Gastric ulcera- tion induced by nonsteroidal anti-inflammatory drugs Is a neutrophil-dependent process. Am. J. Physiol. (1990) 259:G462-G467. First demonstration that neutropenic rats were very resistant to the gastric damaging actions of NSAIDs.
   Google Scholar
• LEE M, LEE AK, FELDMAN M: Aspirin-induced acutegastric mucosal injury is a neutrophil-dependent proc-ess in rats. Am. J. Physiol. (1992) 263: G920–G926.
   PubMed Web of Science ®Google Scholar
• WALLACE JL, ARFORS K-E, MCKNIGHT GW: A monockmal antibody against the CD18 leukocyte adhesion mole-cule prevents indomethacin-induced gastric damage in the rabbit. Gastroenterology (1991) 100:878-883. First demonstration that prevention of leukocyte adherence to the vascular endothelium resulted in prevention of NSAID-induced gastric damage.
   Google Scholar
• WALLACE JL, MCKNIGHT W, MIYASAKA M, TAMATANI T,PAULSON J, ANDERSON DC, GRANGER DN, KUBES P: Role of endothelial adhesion molecules in NSAID-induced gastric mucosal injury. Am. J. Physiol. (1993) 265:G993–G998.
   PubMed Web of Science ®Google Scholar
• KITAHORA T, GUTH PH: Effect of aspirin plus hydro-chloric acid on the gastric mucosal microcirculation. Gastroenterology (1987) 93:810-817. First report identifying leukocyte adherence to the vascular endothe-lium in the gastric microcirculation as an early event following administration of aspirin.
   Google Scholar
• ASAKO H, KUBES P, WALLACE JL, GAGINELLA T, WOLF RE,GRANGER DN: Indomethacin-induced leukocyte adhe-sion in mesenteric venules: role of lipoxygenase prod-ucts. Am. J. Physiol. (1992) 262:G903–G908.
   PubMed Web of Science ®Google Scholar
• ASAKO H, KUBES P, WALLACE JL, WOLF RE, GRANGER DN: Modulation of leukocyte adhesion to rat mesenteric venules by aspirin and salicylate. Gastroenterology (1992) 103:146-152. This paper demonstrated the ability of aspirin to cause leukocytes to adhere to the vascular endothelium of mesenteric venules. Salicylate, on the other hand, did not cause leukocyte adherence.
   Google Scholar
• WALLACE JL, MCCAlTht,RTY D-M, CARTER L, MCKNIGHT W,ARGENTIERI D: Tissue-selective inhibition of pro-staglandin synthesis in rat by tepoxalin: anti-inflamma-tory without gastropathy. Gastroenterology (1993) 105:1630–1636.
   PubMedGoogle Scholar
• ANDREWS FJ, MALCONTENTI-WILSON C, O'BRIEN PE: Ef- fect of nonsteroidal anti-inflammatory drugs on LFA-1 and IC.AM-1 expression in gastric mucosa. Am.J. Physiol. (1994) 266: G657-G664. This paper demonstrated very rapid up-regulation of adhesion molecule expression on the vascular endothelium of gastric blood vessels following NSAID administration.
   Google Scholar
• WALLACE JL, GRANGER DN: The pathogenesis of NSAID- gastropathy - are neutrophils the culprits? Trends Phar-macol. Sci. (1992) 13:129–131.
   Google Scholar
• ASHLEY SW, SONNENSCHEIN LA, CHEUNG LY: Focal gas-tric mucosal blood flow at the site of aspirin-induced ulceration. Am. J. Surg. (1985) 149:53–59.
   PubMed Web of Science ®Google Scholar
• GANA TJ, HUHLEWYCH R, KOO J: Focal gastric mucosal blood flow in aspirin-induced ulceration. Ann. SuT. (1987) 203:399-403. 12.
   Google Scholar
• JACKSON BA, GOLDSTEIN RH, ROY R, COZZANI M, TAY-LOR L, POLGAR P: Effects of transforming growth fac-tor-II and interleukin-113 on expression of cyclooxygenase 1 and 2 and phospholipase Az mRNA In lung fibroblasts and endothelial cells in culture. Biochem. Biophys. Res. Commun. (1993) 197:1465–1474.
   PubMed Web of Science ®Google Scholar
• MARTIN M, NEUMANN D, HOFF T, RESCH K, DEMI]. i DL,GOPPELT-STRUEBE M: Interleulcin-1-induced cyclooxy-genase 2 expression is suppressed by cyclosporin A in rat mesangial cells. Kidney Int. (1994) 45:150–158.
   Google Scholar
• HEMPEL SL, MONICK MM, HUNNINGHAKE GW: Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. j Clin. Invest. (1994) 93:391–396.
   PubMed Web of Science ®Google Scholar
• LYONS-GIORDANO B, PRAITA MA, GALBRAITH W, DAVIS GL, ARNER EC: Interleukin-1 differentially modulates chondrocyte expression of cyclooxygenase-2 and phospholipase Az. Exp. Cell. Res. (1993) 206:58–62.
   PubMed Web of Science ®Google Scholar
• HABIB A, CRÉMINON C, FROBERT Y, GRASSI J, PRADELLES P, MACLOUF J: Demonstration of an inducible cyclooxy-genase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cy-clooxygenase-2.J. Biol. Chem. (1993) 268:23448–23454.
   PubMed Web of Science ®Google Scholar
• VANE JR, MITCHELL JA, APPLETON I, TOMLINSON A, BISHOP-BAILEY D, GROXTALL J, WILLOUGHBY DA: In-ducible isofortns of cyclooxygenase and nitric oxide synthase in inflammation. Proc. Natl. Acad. Sci. USA (1994) 91:2046-2050. This paper demonstrates the time-course of induction of COX-2 and inducible nitric oxide synthase at sites of inflammation.
   Google Scholar
• 'CIE W, ROBERTSON DL, SIMMONS DL: Mitogen-inducible prostaglandin G/H synthase: A new target for non-steroidal anti-inflammatory drugs. Drug Dev. Res. (1992) 25:249–265.
   Google Scholar
• MITCHELL JA, AKARASEREENONT P, THIEMERMANN C,FLOWER RJ, VANE JR: Selectivity of nonsteroklal anti-in-flammatory drugs as inhibitors of constitutive and indudble cyclooxygenase. Proc. Natl. Acad. Sci. USA (1993) 90:11693–11697.
   PubMed Web of Science ®Google Scholar
• MEADE EA, SMITH WL, DEWITT DL: Differential inhibi-tion of prostaglandin endoperoxide synthase (cy-clooxygenase) isozymes by aspirin and other non-steroidal anti-bzflaaunatory drugs. J. Biol. Chem. (1993) 268:6610–6614.
   PubMed Web of Science ®Google Scholar
• MASFERRER JL, ZWEIFEL BS, MANNING PT, HAUSER SD, LEAHY KM, SMITH WG, ISAICSON PC, SEIBERT K: Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and nonulcerogenic. Proc Nall Acad Sci. USA (1994) 91:3228-3232. This paper was the first full report of the effects of a selective COX-2 inhibitor with respect to both anti-inflammatory effects and safety in the gastrointestinal tract.
   Google Scholar
• CHAN CC, GORDON R, BR1DEAU C, RODGER IW, LI CS,PRASIT P, TAGARI P, ETURER D, VICKERS P, BOYCE S, RUPNIAK N, WEBB J, HILL R, FORD-HUTCHINSON AW: In vivo pharmacology of L-745,337: a novel non-steroidal anti-inflammatory agent (NSAID) with an ulcerogenic sparing effect In rat and monkey stomach. Can. J. Physiol. Pharmacol. (1994) 72:266.
   PubMedGoogle Scholar
• ELLIOTT SN, MCKNIGHT W, CIRINO G, WALLACE JL: A nitric oxide-releasing NSAID accelerates gastric ulcer healing in rats. Gastroenterology (1995). In press. Demonstrates that a nitric oxide-releasing NSAID accelerates ulcer healing. Also demonstrates that a 'selective' COX-2 inhibitor mark-edly suppresses COX-1 activity in vivo when given at anti-inflamma-tory doses.
   Google Scholar
• WU ECK, SANDUJA AR, TSAI A, FERHANOGLU B, LOOSE-MITCHELL DS: Aspirin inhibits interleukin 1-induced prostaglandin H synthase expression in cultured endo-thelial cells. Proc. Natl. Acad. Sci. (1991) 88:2384-2387. A very important paper demonstrating that COX-1 can be induced and its levels in endothelial cells greatly increased by exposure to interleukin-1. Furthermore, salicylic acid appears to be capable of inhibiting this induction of COX-I.
   Google Scholar
• SLATER DM, BERGER LC, NEWTON R, MOORE GE, BEN- •NETT PR: Expression of cyclooxygenase types 1 and 2In human fetal membranes at term. Am. J. Obstet. Gyne-col. (1995) 172:77-82. Demonstrates an apparent physiological role for cyclooxygenase-2 in the onset and maintenance of labour.
   Google Scholar
• STADLER P, ARMSTRONG D, MARGALITH D, SARAGA E,STOLTE M, LUALDI P, MAUTONE G, LOUIS A: Diclofenac delays healing of gastroduodenal mucosal lesions. Dou-ble-blind, placebo-controlled endoscopic study in healthy volunteers. Dig. Dis. Sci. (1991) 36:594–600.
   Google Scholar
• MATSUDA K, SAKAMOTO C, MIZUNO H, NOGUCHI H, MATOZAKI T, WADA K, UCHIDA T, KONDA Y, KASUGA M: Gene expression of cyclooxygenase and EGF-like growth factors in different stages of the mouse gastric ulcer. Gastroenterology (1994) 106:A132.
   Web of Science ®Google Scholar
• KAWAHITO Y, SANO H, MUKAI S, ASAI K, KIMURA S, YAMAMURA Y, KATO H, HLA T, KONDO M: Detection of cyclooxygenase-1 and -2-proteins and mRNA in gastric ulcer. Pathophysiology (1994) 1:288.
   Google Scholar
• WHITTLE BJR: Temporal relationship between cy-clooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethadn in the rat. Gastroenterology (1981) 80:94–98.
   PubMed Web of Science ®Google Scholar
• PATRONO C: Aspirin as an antiplatelet drug. New EngLJ Med. (1994) 330:1287–1294.
   PubMed Web of Science ®Google Scholar
• WALLACE JL, REUTER B, CICALA C, MCKNIGHT W, •GRISHAM MB, CIRINO G: Novel nonsteroidal anti-inflam-matory drug derivatives with markedly reduced ukero-genic properties in the rat. Gastroenterology (1994) 107:173-179. First demonstration of the lack of gastrointestinal damage by nitric oxide-releasing NSAIDs, despite significant anti-inflammatory ef-fects.
   Google Scholar
• WALLACE JL, REUTER B, CICALA C, MCKNIGHT W, GRISHAM MB, CIRINO G: A diclofenac derivative without uicerogenic properties. Eur.J. Pharmacol. (1994) 257:249–255.
   PubMed Web of Science ®Google Scholar
• REUTER BK, CIRINO G, WALLACE JL: Markedly reduced intestinal toxicity of a diclofenac derivative. Life Sci. (1994) 55:PL1-PL8. This paper demonstrated the lack of intestinal damage by a nitric oxide-releasing NSAID in a model of pre-existing intestinal inflam-mation.
   Google Scholar
• MITCHELL JA, CIRINO G, AKARASEREENONT P, WALLACEJL, FLOWER RJ, VANE JR: Flurbinitroxybutylester: a novel anti-inflammatory drug devoid of uleerogenic activity, Inhibits cyclooxygenase-1 and cyclo-oxgenase-2. Can. J. Physiol. Pharmacol. (1994) 72:270.
   Google Scholar
• WALLACE JL, KEENAN CM, GALE D, SHOUPE TS: Exacer-bation of experimental colitis by nonsteroidal anti-in-flammatory drugs is not related to elevated leukotriene 84 synthesis. Gastroenterology (1992) 101:18–27
   Google Scholar
• WALLACE JL, MCKNIGHT W, DEL SOLDATO P, CIMINO G:Anti-thrombotic effects of a nitric oxide-generating, gastric-sparing aspirin derivative. Manuscript submitted.
   Google Scholar
• THE SALT COLLABORATIVE GROUP: Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet (1991) 338:1345–1349.
   PubMed Web of Science ®Google Scholar
• MEADE TW, RODERICK PJ, BRENNAN PJ, WILKES HC, KELLEHER CC: Fxtracranial bleeding and other symp-toms due to low dose aspirin and low intensity oral anticoagulation. Thromb. Haemost. (1992) 68:1–6.
   PubMed Web of Science ®Google Scholar
• CRYER B, LUK G, FELDMAN M: Effects of very low dosesof aspirin (ASA) on gastric, duodenal & rectal pro-staglandins (PGs) and mucosal injury. Gastroenterology (1995) 108:A77 (Abstract).
   Google Scholar